Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Ansell Limited

Healthcare US ANSLF

22.74USD
0.00(0%)

Last update at 2026-06-02T13:30:00Z

Day Range

22.7422.74
LowHigh

52 Week Range

20.0225.00
LowHigh

Fundamentals

  • Previous Close 22.74
  • Market Cap3417.11M
  • Volume0
  • P/E Ratio25.81
  • Dividend Yield2.40%
  • EBITDA350.80M
  • Revenue TTM2010.20M
  • Revenue Per Share TTM13.89
  • Gross Profit TTM 847.50M
  • Diluted EPS TTM0.93

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 143.90M 108.70M 188.67M 205.65M 318.10M
Minority interest -2.00000M -1.00000M -1.60000M -1.10000M 13.40M
Net income 101.60M 76.50M 148.30M 158.70M 246.70M
Selling general administrative 641.10M 66.20M 118.13M 79.88M 480.10M
Selling and marketing expenses 641.10M 495.50M 271.55M 295.10M 480.10M
Gross profit 825.00M 624.80M 604.22M 625.19M 810.00M
Reconciled depreciation 74.80M 72.60M 68.00M 65.30M 64.10M
Ebit 185.40M 128.45M 196.67M 225.32M 401.60M
Ebitda 260.20M 202.30M 264.00M 287.45M 401.60M
Depreciation and amortization 74.80M 73.85M 67.33M 62.13M 64.51M
Non operating income net other - - - - -
Operating income 109.10M 129.30M 196.87M 233.62M 401.60M
Other operating expenses 1894.20M 1490.00M 1437.20M 1617.20M 1761.10M
Interest expense 47.01M 25.43M 21.42M 18.87M 19.40M
Tax provision 40.30M 31.20M 39.70M 48.60M 69.80M
Interest income 6.30M 4.40M - - 1.20M
Net interest income -40.00000M -20.60000M -19.40000M -19.70000M -18.20000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 40.30M 31.20M 39.20M 46.08M 69.80M
Total revenue 2003.30M 1619.30M 1634.07M 1850.82M 2026.90M
Total operating expenses 715.90M 495.50M 407.36M 391.57M 544.20M
Cost of revenue 1178.30M 994.50M 1029.84M 1225.63M 1216.90M
Total other income expense net 34.80M -20.60000M -20.90000M -28.20000M 8.10M
Discontinued operations - - - - -
Net income from continuing ops 103.60M 77.50M 149.90M 159.80M 248.30M
Net income applicable to common shares - - 148.30M 158.70M 246.70M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 3322.40M 3242.60M 2530.60M 2506.20M 2737.70M
Intangible assets 320.20M 212.50M 214.40M 1049.40M 225.70M
Earning assets - - - - -
Other current assets 41.30M 41.80M 31.10M 38.10M 37.40M
Total liab 1339.70M 1332.40M 915.20M 949.60M 1173.10M
Total stockholder equity 1963.60M 1894.90M 1600.90M 1542.90M 1551.20M
Deferred long term liab - - - - -
Other current liab 190.10M 111.02M 77.80M 65.80M 171.70M
Common stock 1027.00M 1028.20M 750.70M 743.80M 769.00M
Capital stock 1027.00M 1028.20M 750.70M 743.80M 769.00M
Retained earnings 1097.20M 1059.80M 1026.60M 942.00M 866.80M
Other liab - - 123.60M 121.70M 128.50M
Good will 1335.30M 842.30M 845.30M 834.40M 851.40M
Other assets - 0.00000M 122.10M 95.80M 114.70M
Cash 238.30M 912.30M 159.40M 206.20M 240.20M
Cash and equivalents - - - - -
Total current liabilities 522.00M 423.40M 414.60M 360.30M 549.90M
Current deferred revenue - 9.38M - - -
Net debt 567.30M -55.10000M 334.90M 279.60M 275.30M
Short term debt 81.00M 77.50M 117.30M 18.20M 20.80M
Short long term debt 60.40M 59.70M 100.00M - -
Short long term debt total 805.60M 857.20M 494.30M 485.80M 515.50M
Other stockholder equity - -0.00000M -176.40000M -142.90000M -84.60000M
Property plant equipment - - 436.80M 356.60M 356.00M
Total current assets 1110.80M 1623.90M 912.00M 984.50M 1166.90M
Long term investments 1.10M 5.60M 6.50M 18.00M 21.90M
Net tangible assets - - 541.20M 493.50M 474.10M
Short term investments - 7.18M - - -
Net receivables 246.50M 211.90M 191.20M 201.70M 274.20M
Long term debt 638.50M 706.60M 307.00M 426.30M 451.70M
Inventory 584.70M 457.90M 526.10M 521.30M 611.20M
Accounts payable 250.90M 225.50M 219.50M 276.30M 357.40M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -160.60000M -193.10000M -176.40000M -142.90000M -84.60000M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 40.50M 42.75M 42.00M 32.60M 32.70M
Deferred long term asset charges - - - - -
Non current assets total 2211.60M 1618.70M 1618.60M 1521.70M 1570.80M
Capital lease obligations 106.70M 90.90M 87.30M 59.50M 63.80M
Long term debt total - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -703.30000M -63.40000M -75.50000M -5.10000M -1.70000M
Change to liabilities - - -78.90000M -94.70000M 124.20M
Total cashflows from investing activities -703.30000M - -75.50000M -71.20000M -84.70000M
Net borrowings -82.00000M - -59.50000M -17.10000M -112.10000M
Total cash from financing activities -216.00000M 540.80M -149.20000M -176.70000M -267.50000M
Change to operating activities - - 0.70M -48.90000M 16.10M
Net income 101.60M 77.82M 148.30M 158.70M 246.70M
Change in cash -674.00000M 752.90M -46.80000M -34.00000M -168.70000M
Begin period cash flow 912.30M 159.40M 206.20M 240.20M 408.90M
End period cash flow 238.30M 912.30M 159.40M 206.20M 240.20M
Total cash from operating activities 239.30M 272.30M 180.50M 222.00M 172.80M
Issuance of capital stock - 305.20M -0.30000M 103.20M -
Depreciation - 73.85M 68.00M 60.20M 57.40M
Other cashflows from investing activities 1.30M - 2.70M 2.70M 2.70M
Dividends paid 63.70M 53.20M 62.90M 86.80M 77.30M
Change to inventory -95.13943M 61.40M 8.80M 67.90M -260.50000M
Change to account receivables -21.22107M -23.39704M 14.80M 59.10M -80.90000M
Sale purchase of stock -4.40000M -30.00000M -8.00000M -48.50000M -58.00000M
Other cashflows from financing activities -65.90000M -43.37597M -19.20000M -45.80000M -20.80000M
Change to netincome - - 15.10M 32.90M 46.70M
Capital expenditures 69.30M 62.80M 67.30M 72.60M 82.70M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -48.33124M 37.60M -46.63450M -51.85680M -172.70562M
Stock based compensation - 6.20M -5.50000M -2.60000M 30.10M
Other non cash items 287.63M 76.83M 22.23M 47.15M 16.29M
Free cash flow 170.00M 195.01M 113.20M 149.40M 90.10M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ANSLF
Ansell Limited		 - -% 22.74 25.81 19.34 1.70 1.64 1.68 11.15
ISRG
Intuitive Surgical Inc		 4.99 1.24% 407.29 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 - -% 196.12 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -0.98 0.99% 98.17 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 1.18 0.82% 145.61 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for various industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. It sells provides its products under ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, Kimtech, KleenGuard, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, TouchNTuff, and VIKING brands. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Ansell Limited

678 Victoria Street, Richmond, VIC, Australia, 3121

Key Executives

Name Title Year Born
Mr. Neil I. Salmon ACMA, BA MD, CEO & Director 1969
Mr. Zubair Javeed Chief Financial Officer NA
Mr. Darryl Nazareth Pres of Healthcare GBU NA
Mr. Rikard Fröberg MA, MS Pres of the Industrial Global Bus. Unit (IGBU) NA
Mr. John Marsden Sr. VP of Global Operations & Global Supply Chain NA
Ms. Deanna Johnston Sr. VP & Global Chief Information Officer NA
Michael Evans Director of Corp. Devel. & Investor Relation NA
Mr. Michael Gilleece Sr. VP & Corp. Gen. Counsel NA
Ms. Amanda Manzoni Chief HR Officer NA
Mr. Francois Le Jeune BS, MBA, MS Chief Commercial Officer of EMEA, APAC & Guardian Admin. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions